Towa Pharmaceutical Co., Ltd.
OTC: TWAPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Itsuro Yoshida
- Employees
- 4,588
- Headquarters
- Osaka, Japan
- IPO year
- 2009
- Market cap
- $828.5M
- Website
- https://www.towayakuhin.co.jp
Loading TWAPF…
Loading profile data…Frequently asked questions about TWAPF
What does Towa Pharmaceutical Co., Ltd. (TWAPF) do?
Operating in Japan, Towa Pharmaceutical Co., Ltd. and its subsidiaries are engaged in the research, development, production, and sale of prescription drugs, active pharmaceutical ingredients, and intermediates. The company's extensive portfolio addresses critical therapeutic areas such as diabetes, digestive health, neurological conditions, and...
Where does TWAPF trade?
Towa Pharmaceutical Co., Ltd. (TWAPF) trades on the Other OTC.
What sector is TWAPF in?
Towa Pharmaceutical Co., Ltd. (TWAPF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Towa Pharmaceutical Co., Ltd.?
Itsuro Yoshida is the chief executive officer of Towa Pharmaceutical Co., Ltd. (TWAPF).
Where is Towa Pharmaceutical Co., Ltd. headquartered?
Towa Pharmaceutical Co., Ltd. is headquartered in Japan.
Does TWAPF pay a dividend?
Yes — Towa Pharmaceutical Co., Ltd. (TWAPF) paid a trailing twelve-month dividend of USD 0.52 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TWAPF go public?
Towa Pharmaceutical Co., Ltd. (TWAPF) completed its initial public offering in 2009.